From 3/31 to 7/21 Implant Sciences management kept silent and failed to report it was in default on it's loans. Meanwhile investors kept buying and the shares traded higher.
The 50 million new shares that were appoved by a vote at the annual shareholder meeting in July 2015 could have been sold in a private placement to pay down debt. At that time the shares were trading atound .70 Instead they are now going to be sold to PP as warrants for .19
Clearly they have not acted responsibly and in the best interest of shareholders.
News 
Market Data 
Discover 
